Ozawa K - Search Results

1

Mesenchymal stromal cells inhibit Th17 but not regulatory T-cell differentiation.

Tatara R, Ozaki K, Kikuchi Y, Hatanaka K, Oh I, Meguro A, Matsu H, Sato K, Ozawa K. Tatara R, et al. Among authors: ozawa k. Cytotherapy. 2011 Jul;13(6):686-94. doi: 10.3109/14653249.2010.542456. Epub 2010 Dec 20. Cytotherapy. 2011. PMID: 21171824

2

Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells.

Sato K, Ozaki K, Oh I, Meguro A, Hatanaka K, Nagai T, Muroi K, Ozawa K. Sato K, et al. Among authors: ozawa k. Blood. 2007 Jan 1;109(1):228-34. doi: 10.1182/blood-2006-02-002246. Epub 2006 Sep 19. Blood. 2007. PMID: 16985180 Free article.

3

Mesenchymal stromal cells for graft-versus-host disease : basic aspects and clinical outcomes.

Sato K, Ozaki K, Mori M, Muroi K, Ozawa K. Sato K, et al. Among authors: ozawa k. J Clin Exp Hematop. 2010;50(2):79-89. doi: 10.3960/jslrt.50.79. J Clin Exp Hematop. 2010. PMID: 21123965 Free article. Review.

4

Interferon-gamma and NF-kappaB mediate nitric oxide production by mesenchymal stromal cells.

Oh I, Ozaki K, Sato K, Meguro A, Tatara R, Hatanaka K, Nagai T, Muroi K, Ozawa K. Oh I, et al. Among authors: ozawa k. Biochem Biophys Res Commun. 2007 Apr 20;355(4):956-62. doi: 10.1016/j.bbrc.2007.02.054. Epub 2007 Feb 21. Biochem Biophys Res Commun. 2007. PMID: 17336935

5

Screening of genes responsible for differentiation of mouse mesenchymal stromal cells by DNA micro-array analysis of C3H10T1/2 and C3H10T1/2-derived cell lines.

Oh I, Ozaki M, Miyazato A, Sato K, Meguro A, Muroi K, Nagai T, Mano H, Ozawa K. Oh I, et al. Among authors: ozawa k. Cytotherapy. 2007;9(1):80-90. doi: 10.1080/14653240601016374. Cytotherapy. 2007. PMID: 17361490

6

Mechanisms of immunomodulation by mesenchymal stem cells.

Ozaki K, Sato K, Oh I, Meguro A, Tatara R, Muroi K, Ozawa K. Ozaki K, et al. Among authors: ozawa k. Int J Hematol. 2007 Jul;86(1):5-7. doi: 10.1532/IJH97.07003. Int J Hematol. 2007. PMID: 17675259 Review.

7

Cell and gene therapy using mesenchymal stem cells (MSCs).

Ozawa K, Sato K, Oh I, Ozaki K, Uchibori R, Obara Y, Kikuchi Y, Ito T, Okada T, Urabe M, Mizukami H, Kume A. Ozawa K, et al. J Autoimmun. 2008 May;30(3):121-7. doi: 10.1016/j.jaut.2007.12.008. Epub 2008 Jan 31. J Autoimmun. 2008. PMID: 18249090 Review.

8

Altered effector CD4+ T cell function in IL-21R-/- CD4+ T cell-mediated graft-versus-host disease.

Oh I, Ozaki K, Meguro A, Hatanaka K, Kadowaki M, Matsu H, Tatara R, Sato K, Iwakura Y, Nakae S, Sudo K, Teshima T, Leonard WJ, Ozawa K. Oh I, et al. Among authors: ozawa k. J Immunol. 2010 Aug 1;185(3):1920-6. doi: 10.4049/jimmunol.0902217. Epub 2010 Jun 23. J Immunol. 2010. PMID: 20574002 Free PMC article.

9

IL-21 is critical for GVHD in a mouse model.

Meguro A, Ozaki K, Oh I, Hatanaka K, Matsu H, Tatara R, Sato K, Leonard WJ, Ozawa K. Meguro A, et al. Among authors: ozawa k. Bone Marrow Transplant. 2010 Apr;45(4):723-9. doi: 10.1038/bmt.2009.223. Epub 2009 Aug 31. Bone Marrow Transplant. 2010. PMID: 19718060 Free PMC article.

10

Lack of IL-21 signal attenuates graft-versus-leukemia effect in the absence of CD8 T-cells.

Meguro A, Ozaki K, Hatanaka K, Oh I, Sudo K, Ohmori T, Matsu H, Tatara R, Sato K, Sakata Y, Nakae S, Leonard WJ, Ozawa K. Meguro A, et al. Among authors: ozawa k. Bone Marrow Transplant. 2011 Dec;46(12):1557-65. doi: 10.1038/bmt.2010.342. Epub 2011 Jan 24. Bone Marrow Transplant. 2011. PMID: 21258423 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,077 results

Search Page

Filters